Company: KRKA Pharma Dublin Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Esomeprazole 20mg, 40mg. Description: 20mg: Slightly pink gastro-resistant hard capsule containing white pellets. 40mg: Off-pink gastro-resistant hard capsule containing white pellets. Presentations: 20mg-28, €17.28; 40mg-28, €25.86. Indications: Gastroesophageal reflux disease (GORD): Treatment of erosive reflux oesophagitis (RO); long-term management of healed oesophagitis [...]
Company: KRKA Pharma Dublin Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pantoprazole 20mg, 40mg. Description: Light brownish-yellow, oval, slightly biconvex gastro-resistant tablets. Presentations: 20mg-28, €8.18; 40mg-28, €15.12. Indications: Nolpaza 20mg: Adults and adolescents 12 years and above: Symptomatic gastro-oesophageal reflux disease (GORD); long-term management and prevention of relapse in reflux oesophagitis (RO). Adults: [...]
Results of a recent study at St James’s Hospital on 47 GORD patients undergoing upper-GI pH manometry indicated that a small increase in BMI leads to a dramatic increase in reflux. Waist circumference was more significantly associated with reflux than BMI.
Gastro-oesophageal reflux disease (GORD) is a common condition that is due to the acid in the stomach washing back into the oesophagus. There is a wide range of medications available now, as well as surgical options, which were not around 20 years ago.
Company: Clonmel Healthcare. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Esomeprazole (as magnesium dihydrate) 20mg, 40mg. Description: 20mg: Opaque yellow and white gastro-resistant hard capsule marked 20mg, containing off-white to greyish spherical microgranules. 40mg: Opaque yellow gastro-resistant hard capsule marked 40mg, containing off-white to greyish spherical microgranules. Presentation: 20mg-28, €20.09; 40mg-28, €30.92. Indications: Treatment [...]
Company: Actavis Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Rabeprazole (Na+) 10mg, 20mg. Description: Respectively pink and yellow, elliptical, biconvex, gastro-resistant, coated tablets. Presentation: 10mg-28; 20mg-28. Indications: Treatment of active duodenal ulcers; active benign gastric ulcers; symptomatic erosive or ulcerative gastroesophageal reflux disease (GORD). Long-term management of GORD. Symptomatic treatment of moderate [...]
Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Rabeprazole (Na+) 10mg. Description: Pink, round, biconvex, film-coated, gastro-resistant tablets. Presentation: 28, €11.62. Indications: Treatment of active duodenal ulcers; active benign gastric ulcers; symptomatic erosive or ulcerative gastroesophageal reflux disease (GORD). Long-term maintenance of GORD. Symptomatic treatment of moderate to very severe GORD. Zollinger-Ellison [...]
The relationship between Gastro-Oesophageal Reflux (GOR) and lung disease goes both ways. GOR has potential effects on lungs by increasing cough reflex and causing micro-aspiration. GOR may also stimulate interconnecting neural (vagal) pathways (via synergistic interactions between oesophageal and airway nociceptors) which may result in bronchoconstriction.1 Acid may also induce the release of tachykinins including [...]
View the pdf version: GORD algorithm – Clinical Special January 2011
Accurate assessment of symptoms is a critical but under-used step in diagnosing gastro-oesophageal reflux disease, Australian gastroenterologists have argued. Prof Richard Holloway and Dr Paul Kuo, from the Royal Adelaide Hospital, said it was time to implement questionnaires to standardise symptom-based diagnosis. “In comparison with endoscopy, the evaluation of the accuracy of symptoms for the [...]
Loading ...
